Pregled bibliografske jedinice broj: 547047
Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after 3 amputation in rats treated with heparin, warfarin or aspirin
Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after 3 amputation in rats treated with heparin, warfarin or aspirin // Thrombosis research, 129 (2012), 5; 652-659 doi:10.1016/j.thromres.2011.07.035 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 547047 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Pentadecapeptide BPC 157 reduces bleeding time and thrombocytopenia after 3 amputation in rats treated with heparin, warfarin or aspirin
Autori
Stupnišek, Mirjana ; Franjić, Sandra ; Drmić, Domagoj ; Hrelec, Maša ; Kolenc, Danijela ; Radić, Božo ; Bojić, Davor ; Včev, Aleksandar ; Seiwerth, Sven ; Sikirić, Predrag
Izvornik
Thrombosis research (0049-3848) 129
(2012), 5;
652-659
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
BPC 157; bleeding; amputation; heparin; warfarin; aspirin challenge
Sažetak
Recently, in rat abdominal aorta terminoterminal-anastomosis the stable gastric pentadecapeptide BPC 157 prevents obstructive thrombus formation and rapidly destroys already formed obstructive thrombus. Also, BPC 157 wound healing may signify the clot as conductive matrix or “scaffold” to speed up wound healing process, and decrease bleeding. Here, in rats, BPC 157 (10 μg/kg, 10 ng/kg) improved always reduced bleeding time and amount of bleeding after (tail) amputation only, heparin (250 mg/kg, 25 mg/kg, 10 mg/kg i.v.), warfarin (1.5 mg/kg i.g. once daily for 3 consecutive days), aspirin (0.1 g/kg i.g. (once daily/3 consecutive days) or 1.0 g/kg i.p. once), and amputation associated with those agents application. BPC 157 counteracting regimens (i.v., i.p., i.g. (immediately after any challenge)) correspondingly followthe route of bleeding-agents application. All heparin-, warfarin-, and aspirin-rats and normal-rats that received BPC 157 exhibited lesser fall in platelets count. BPC 157 attenuated over-increased APTT-, TT-values in 10 mg/kg heparin-rats, but did not influence heparin activity (anti-Xa test). Indicatively, unless counteracted in BPC 157 rats, excessive bleeding-acute thrombocytopenia (b20% of initial values in heparin-rats) approaches substantial fall in platelets count known in type II HIT. Also, BPC 157 markedly prolongs the survival time (heparin-rats, 25 mg/kg, right foot amputation).
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
108-1083570-3635 - Pentadekapeptid BPC 157 - daljnja istraživanja (Sikirić, Predrag, MZOS ) ( CroRIS)
108-1083570-3643 - Kvantitativna analiza i prijenos slike u patologiji (Seiwerth, Sven, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb
Profili:
Predrag Sikirić
(autor)
Mirjana Stupnišek
(autor)
Sven Seiwerth
(autor)
Aleksandar Včev
(autor)
Danijela Kolenc
(autor)
Sandra Vitaić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE